Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Preferred Shares (2016 - 2017)

Historic Preferred Shares for UroGen Pharma (URGN) over the last 1 years, with Q4 2016 value amounting to $13000.0.

  • UroGen Pharma's Preferred Shares changed N/A to $13000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $13000.0, marking a year-over-year change of. This contributed to the annual value of $13000.0 for FY2016, which is N/A changed from last year.
  • Per UroGen Pharma's latest filing, its Preferred Shares stood at $13000.0 for Q4 2016.
  • Over the past 5 years, UroGen Pharma's Preferred Shares peaked at $13000.0 during Q4 2016, and registered a low of $13000.0 during Q4 2016.